GPT and metabolic syndrome: Individuals aged ≥ 10 years (high-risk group), combined with biomarkers such as ALT, GGT, Hcy, SOD, and PLT—which are linked to hepatic injury, oxidative stress, and renal/metabolic dysfunction—provide a novel multifactorial framework for dyslipidemia risk stratification in WD.